Bellevue Group »

Fate Therapeutics shares owned by Bellevue Group

Quarter-by-quarter ownership of Fate Therapeutics (FATE) shares owned by Bellevue Group from 13F filings

Historical chart of Bellevue Group investment in Fate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fate Therapeutics held by Bellevue Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fate Therapeutics by Bellevue Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $18M 4.9M 3.74
2023-09-30 $10M 4.9M 2.12
2023-06-30 $23M 4.9M 4.76
2023-03-31 $28M 4.9M 5.70
2022-12-31 $49M 4.9M 10.09
2022-09-30 $84M 3.7M 22.41
2022-06-30 $88M 3.6M 24.78
2022-03-31 $139M 3.6M 38.77
2021-12-31 $221M 3.8M 58.51
2021-09-30 $192M 3.2M 59.27
2021-06-30 $227M 2.6M 86.79
2021-03-31 $182M 2.2M 82.46
2020-12-31 $192M 2.1M 90.93
2020-09-30 $89M 2.2M 39.97
2020-06-30 $67M 2.0M 34.31
2020-03-31 $35M 1.6M 22.21
2019-12-31 $1.6M 83k 19.57
2019-09-30 $933k 60k 15.52
2019-06-30 $1.2M 59k 20.31